Steve Hopkins

Interleukin-1 receptor antagonist in animal models of stroke: a fair summing up?

B. McColl, A. Parry-Jones, S. Allan, 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices

A. Pestronk, L. Gutmann, C. Karam, 2021, Neurology: Genetics.

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

Peripheral inflammatory markers in amnestic mild cognitive impairment

A. Burns, Julie Morris, P. Tyrrell, 2013, International journal of geriatric psychiatry.